Cost effectiveness of bevacizumab + chemotherapy in the treatment of metastatic colorectal cancer in the Czech Republic: a real clinical practice study

Trial Profile

Cost effectiveness of bevacizumab + chemotherapy in the treatment of metastatic colorectal cancer in the Czech Republic: a real clinical practice study

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2012

At a glance

  • Drugs Bevacizumab (Primary) ; Antineoplastics
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2012 New trial record
    • 07 Nov 2012 Results presented at the 15th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top